The BPA is for point of care for whole blood glucose testing, cost per test (CPT) reagents and analyzer service.
Ended Awarded Last action
- Contract number
- 36C25521N0341
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $84,416
Award facts
- Contract value 46% obligated
- $184,170.20 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$99,754 | |
| Original award | $184,170 |
About this award
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation for point-of-care whole blood glucose testing reagents and analyzer service. The BPA has a ceiling value of $184,170.20 and a performance period ending on May 31, 2023. The contract was awarded on June 1, 2021 under the VA's Indefinite Delivery, Indefinite Quantity (IDIQ) contract for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII) through the General Services Administration (GSA) schedule. This BPA does not have a set-aside designation, and Roche Diagnostics, a manufacturer of in vitro diagnostics and laboratory equipment, is the prime contractor. The contract will provide the VA's healthcare facilities with glucose testing reagents and associated analyzer service to support patient care.
Quick answers
Who was awarded contract 36C25521N0341?
36C25521N0341 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2021.
How much is contract 36C25521N0341 worth?
The government has obligated $84,416 on 36C25521N0341. Its current value, with exercised options, is $184,170.
Is contract 36C25521N0341 an order under another contract?
Yes. 36C25521N0341 is a BPA call under V797P5279B-36C25518A0030, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25521N0341 competed?
The extent of competition for 36C25521N0341 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award